These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7970963)

  • 1. Evaluation of prophylaxis against invasive pneumococcal infections in human immunodeficiency virus-infected children.
    Peters VB; Hyatt AC; Schechter C; Diamant EP; Hodes DS
    Pediatr Infect Dis J; 1994 Jul; 13(7):667-9. PubMed ID: 7970963
    [No Abstract]   [Full Text] [Related]  

  • 2. The epidemiology of pneumococcal infection in children in the developing world.
    Greenwood B
    Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):777-85. PubMed ID: 10365403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active immunization in HIV-infected patients.
    Pau AK; McNicholl IR; Pursell KJ
    Pharmacotherapy; 1996; 16(2):163-70. PubMed ID: 8820461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine.
    Madhi SA; Adrian P; Kuwanda L; Jassat W; Jones S; Little T; Soininen A; Cutland C; Klugman KP
    Vaccine; 2007 Mar; 25(13):2451-7. PubMed ID: 17023095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization--in HIV-Infected and HIV-uninfected children.
    Madhi SA; Adrian P; Kuwanda L; Cutland C; Albrich WC; Klugman KP
    J Infect Dis; 2007 Dec; 196(11):1662-6. PubMed ID: 18008250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flu and pneumococcal immunisations in HIV-infected children: methodological quality of current recommendations.
    Giannattasio A; Lo Vecchio A; Albano F; Giacomet V; Barbarino A; Guarino A
    BMJ Qual Saf; 2011 May; 20(5):432-9. PubMed ID: 21292690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults.
    Chen M; Ssali F; Mulungi M; Awio P; Yoshimine H; Kuroki R; Furumoto A; Tanimura S; Kityo C; Nagatake T; Mugyenyi P; Oishi K
    Vaccine; 2008 Sep; 26(38):4962-8. PubMed ID: 18639599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: one year follow-up study.
    Falcó V; Jordano Q; Cruz MJ; Len O; Ribera E; Campins M; Crespo M; Ocaña I; Rodrigo MJ; Pahissa A
    Vaccine; 2006 Mar; 24(14):2567-74. PubMed ID: 16423429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pneumococcal vaccine recommended for HIV-infected individuals].
    Hoel T; Espinoza R
    Tidsskr Nor Laegeforen; 1993 Jun; 113(16):2010-1. PubMed ID: 8322355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006.
    Steenhoff AP; Wood SM; Rutstein RM; Wahl A; McGowan KL; Shah SS
    Pediatr Infect Dis J; 2008 Oct; 27(10):886-91. PubMed ID: 18776825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence.
    Turett GS; Blum S; Fazal BA; Justman JE; Telzak EE
    Clin Infect Dis; 1999 Aug; 29(2):321-7. PubMed ID: 10476736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination.
    Dworkin MS; Ward JW; Hanson DL; Jones JL; Kaplan JE;
    Clin Infect Dis; 2001 Mar; 32(5):794-800. PubMed ID: 11229848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virus.
    King JC; Borkowsky W; Mahidhara N; Madore D; Shapiro ED; Rutstein RM; Tan TQ; Farley JJ; Dankner WM; Nachman S; Simoes E; Flynn PM; Clemens J; Hamilton RG
    J Infect Dis; 2000 May; 181(5):1817-21. PubMed ID: 10823792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsonic function of bronchoalveolar lavage IgG after pneumococcal vaccination in HIV-infected and uninfected adults.
    Tam JC; Grant NL; Freire-Moran L; Tolmie H; French N; Gordon SB
    J Allergy Clin Immunol; 2009 Jun; 123(6):1420-1. PubMed ID: 19423153
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of invasive pneumococcal disease in HIV-infected children: expanding the toolbox.
    Abzug MJ; Pelton SI
    J Infect Dis; 2009 Apr; 199(8):1109-11. PubMed ID: 19265480
    [No Abstract]   [Full Text] [Related]  

  • 16. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE; Hu DJ; Holmes KK; Jaffe HW; Masur H; De Cock KM
    Am J Trop Med Hyg; 1996 Jul; 55(1):1-11. PubMed ID: 8702012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of effectiveness of daily oral penicillin v prophylaxis in the prevention of pneumococcal infection in children with sickle cell anaemia.
    Gwaram HA; Gwaram BA
    Niger J Med; 2014; 23(2):118-29. PubMed ID: 24956685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of intravenous 7S immunoglobulins at high doses in HIV-related immunological pathology].
    Fiori GP
    Clin Ter; 1994 Apr; 144(4):301-5. PubMed ID: 8205754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination.
    Adamkiewicz TV; Sarnaik S; Buchanan GR; Iyer RV; Miller ST; Pegelow CH; Rogers ZR; Vichinsky E; Elliott J; Facklam RR; O'Brien KL; Schwartz B; Van Beneden CA; Cannon MJ; Eckman JR; Keyserling H; Sullivan K; Wong WY; Wang WC
    J Pediatr; 2003 Oct; 143(4):438-44. PubMed ID: 14571216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.